Targeting the isoprenoid pathway to abrogate progression of pulmonary fibrosis.

Autor: Osborn-Heaford HL; Department of Internal Medicine, University of Iowa., Murthy S; Department of Internal Medicine, University of Iowa., Gu L; Deparment of Medicine, University of Alabama at Birmingham, AL., Larson-Casey JL; Free Radical and Radiation Biology Program, University of Iowa.; Deparment of Medicine, University of Alabama at Birmingham, AL., Ryan AJ; Department of Internal Medicine, University of Iowa., Shi L; Human Toxicology Program, University of Iowa., Glogauer M; Canadian Institutes of Health Research Group in Matrix Dynamics, University of Toronto, Toronto, Ontario, Canada., Neighbors JD; Department of Chemistry, University of Iowa., Hohl R; Department of Internal Medicine, University of Iowa.; Department of Pharmacology, University of Iowa., Carter AB; Department of Internal Medicine, University of Iowa.; Free Radical and Radiation Biology Program, University of Iowa.; Human Toxicology Program, University of Iowa.; Deparment of Medicine, University of Alabama at Birmingham, AL.; Iowa City VA Healthcare System, Iowa City, IA.; Birmingham VAMC, Birmingham, AL.

Publikováno v: Free radical biology & medicine [Free Radic Biol Med] 2015 Sep; Vol. 86, pp. 47-56. Date of Electronic Publication: 2015 May 07.